{"id":"NCT02963935","sponsor":"Novo Nordisk A/S","briefTitle":"Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting","officialTitle":"Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-02-06","primaryCompletion":"2018-05-23","completion":"2018-06-19","firstPosted":"2016-11-15","resultsPosted":"2019-07-30","lastUpdate":"2020-03-11"},"enrollment":282,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Metabolism and Nutrition Disorder","Obesity"],"interventions":[{"type":"DRUG","name":"liraglutide","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"BEHAVIORAL","name":"CMS Intensive Behavior Therapy","otherNames":[]}],"arms":[{"label":"Liraglutide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This trial is conducted in the United States of America (USA). The purpose of the trial is to investigate the effect and safety of liraglutide 3.0 mg as an adjunct to intensive behaviour therapy for obesity in a non-specialist setting (IBT-CMS: Intensive Behaviour Therapy for obesity in a primary care setting according to Centers for Medicare \\& Medicaid Services (CMS) visit schedule).","primaryOutcome":{"measure":"Change in Body Weight (%)","timeFrame":"Week 0, week 56","effectByArm":[{"arm":"Liraglutide 3.0 mg","deltaMin":-7.4,"sd":7.9},{"arm":"Placebo","deltaMin":-4,"sd":7.4}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0003"},{"comp":"OG000 vs OG001","p":"0.0000"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":10},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":["32090517"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":142},"commonTop":["Nausea","Constipation","Diarrhoea","Upper respiratory tract infection","Vomiting"]}}